IRIDEX (IRIX) Competitors $1.52 0.00 (-0.33%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IRIX vs. TELA, FONR, SRTS, MGRM, ICAD, MLSS, EDAP, NTRB, NSPR, and LUCDShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include TELA Bio (TELA), FONAR (FONR), Sensus Healthcare (SRTS), Monogram Orthopaedics (MGRM), iCAD (ICAD), Milestone Scientific (MLSS), Edap Tms (EDAP), Nutriband (NTRB), InspireMD (NSPR), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. IRIDEX vs. TELA Bio FONAR Sensus Healthcare Monogram Orthopaedics iCAD Milestone Scientific Edap Tms Nutriband InspireMD Lucid Diagnostics TELA Bio (NASDAQ:TELA) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Do insiders & institutionals have more ownership in TELA or IRIX? 94.3% of TELA Bio shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 6.0% of TELA Bio shares are held by company insiders. Comparatively, 7.3% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer TELA or IRIX? In the previous week, IRIDEX had 1 more articles in the media than TELA Bio. MarketBeat recorded 2 mentions for IRIDEX and 1 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.92 beat IRIDEX's score of 0.00 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive IRIDEX 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate TELA or IRIX? TELA Bio currently has a consensus target price of $9.25, indicating a potential upside of 240.07%. IRIDEX has a consensus target price of $2.00, indicating a potential upside of 32.89%. Given TELA Bio's stronger consensus rating and higher possible upside, equities analysts plainly believe TELA Bio is more favorable than IRIDEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00IRIDEX 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is TELA or IRIX more profitable? IRIDEX has a net margin of -22.79% compared to TELA Bio's net margin of -60.49%. IRIDEX's return on equity of -192.95% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-60.49% -556.18% -63.13% IRIDEX -22.79%-192.95%-33.97% Which has more risk & volatility, TELA or IRIX? TELA Bio has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, IRIDEX has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Which has better earnings & valuation, TELA or IRIX? IRIDEX has lower revenue, but higher earnings than TELA Bio. IRIDEX is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$68.65M1.56-$46.66M-$1.69-1.61IRIDEX$51.87M0.48-$9.57M-$0.67-2.25 Does the MarketBeat Community favor TELA or IRIX? IRIDEX received 213 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.68% of users gave TELA Bio an outperform vote while only 63.70% of users gave IRIDEX an outperform vote. CompanyUnderperformOutperformTELA BioOutperform Votes5974.68% Underperform Votes2025.32% IRIDEXOutperform Votes27263.70% Underperform Votes15536.30% SummaryTELA Bio beats IRIDEX on 10 of the 18 factors compared between the two stocks. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXElectromedical equipment IndustryComputer SectorNASDAQ ExchangeMarket Cap$25.04M$3.40B$26.21B$8.98BDividend YieldN/A1.65%2.75%3.85%P/E Ratio-2.2516.9646.3418.82Price / Sales0.4874.902,534.8680.74Price / CashN/A45.9935.5737.47Price / Book2.553.866.864.64Net Income-$9.57M$92.00M$731.18M$245.69M7 Day Performance-2.90%4.33%-2.01%-2.63%1 Month Performance-8.79%7.66%0.09%-2.37%1 Year Performance-38.57%13.25%20.24%13.65% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX0.9642 of 5 stars$1.51-1.0%$2.00+32.9%-38.6%$25.04M$51.87M-2.25120Analyst ForecastNews CoverageTELATELA Bio2.8073 of 5 stars$2.67flat$9.25+246.4%-61.1%$105.17M$58.45M-1.58120Positive NewsFONRFONAR2.2093 of 5 stars$16.01+2.6%N/A-35.7%$101.34M$102.88M11.44480Earnings ReportNews CoverageSRTSSensus Healthcare1.9855 of 5 stars$6.07+3.9%$14.67+141.6%+15.2%$99.49M$41.81M15.1840High Trading VolumeMGRMMonogram Orthopaedics3.7979 of 5 stars$2.82+1.1%$4.00+41.8%-24.9%$96.75M$370,000.00-6.0028News CoverageICADiCAD0.5813 of 5 stars$3.60+10.1%N/A+92.9%$95.54M$17.32M-27.69140Analyst UpgradeNews CoverageGap UpMLSSMilestone Scientific0.8096 of 5 stars$1.21-2.4%$1.25+3.3%+57.3%$94.25M$9.83M-17.2830News CoverageEDAPEdap Tms2.8598 of 5 stars$2.53+1.0%$19.00+652.5%-57.2%$93.68M$65.42M-3.88230NTRBNutriband2.5668 of 5 stars$7.15-8.5%$13.00+81.8%+205.7%$79.44M$2.09M-10.0710NSPRInspireMD2.414 of 5 stars$2.98+8.0%$4.75+59.4%+22.5%$77.72M$6.20M-3.9750Analyst ForecastHigh Trading VolumeLUCDLucid Diagnostics3.1763 of 5 stars$1.30+21.5%$3.63+178.8%+13.2%$77.14M$2.43M-1.1470News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies TELA Alternatives FONR Alternatives SRTS Alternatives MGRM Alternatives ICAD Alternatives MLSS Alternatives EDAP Alternatives NTRB Alternatives NSPR Alternatives LUCD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRIX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.